Trial Profile
Predictors of Gastrointestinal Bleeding Among Patients With Atrial Fibrillation Initiating Dabigatran and Subsequent Patterns of Use
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism; Stroke
- Focus Adverse reactions
- 08 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.